Finding telltale mutations in tumors and targeting those cancers with precisely selected drugs is the newest front in the war on cancer. Now researchers just have to figure out why it doesn’t work for everyone.
An audacious startup thinks it can give 40-ish women a better shot at having children. Should desperate would-be parents believe it?
A majority of patients in a small clinical trial have been in remission from a deadly type of cancer for more than four years.
Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.
People voice concerns about drugs via search queries—and that data that can predict when one might be recalled.
Many genetic conditions come with clues in a person’s face, and new technology can help doctors diagnose them.
Synthetic biologists seek to make perfumes from extinct trees and flowers.
DARPA scientists think they can use insects to deliver genetic changes to crops.
Companies are racing to develop a new type of cancer therapy, but scientists are still assessing its safety.
When a woman gets her genome sequenced, questions about privacy arise for her identical twin sister.